Tender detail
Conclusion of non-exclusive rebate agreements for the active substance ustekinumab from 1 January 2027
Summary
GWQ ServicePlus AG is seeking non-exclusive medicine rebate agreements with pharmaceutical companies for medicines containing the active substance ustekinumab, supplied at the expense of statutory health insurers. The agreements are intended to apply from 1 January 2027 until any exclusive medicine rebate agreements take effect.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.